drugset / Trial / NCT04891185
Visualisation of Indocyanine Green in Primary and Interval Debulking for Ovarian Cancer
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
Visualise peritoneal lesions of epithelial ovarian cancer (EOC) in both primary and interval debulking surgery by using intravascular indocyanine green (ICG) and near-infrared (NIR) light. This Trial wants to investigate whether ICG can increase the visibility of peritoneal lesions and can differentiate between peritoneal implants and fibrosis.
Timeline
- Start
- 2021-10-01
- Primary completion
- 2023-10-01
- Completion
- 2023-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.25 mg/kg | Intravenous |